GoodRx Holdings (GDRX) Treasury Shares (2020 - 2025)
GoodRx Holdings' Treasury Shares history spans 6 years, with the latest figure at $20.0 million for Q4 2025.
- On a quarterly basis, Treasury Shares fell 10.59% to $20.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.0 million, a 10.59% decrease, with the full-year FY2025 number at $20.0 million, down 10.59% from a year prior.
- Treasury Shares hit $20.0 million in Q4 2025 for GoodRx Holdings, roughly flat from $20.0 million in the prior quarter.
- Over the last five years, Treasury Shares for GDRX hit a ceiling of $22.4 million in Q4 2024 and a floor of $939000.0 in Q2 2021.
- Historically, Treasury Shares has averaged $11.3 million across 5 years, with a median of $10.2 million in 2022.
- Biggest five-year swings in Treasury Shares: tumbled 87.63% in 2023 and later skyrocketed 1736.56% in 2024.
- Tracing GDRX's Treasury Shares over 5 years: stood at $5.6 million in 2021, then soared by 49.8% to $8.5 million in 2022, then skyrocketed by 41.91% to $12.0 million in 2023, then skyrocketed by 86.41% to $22.4 million in 2024, then dropped by 10.59% to $20.0 million in 2025.
- Business Quant data shows Treasury Shares for GDRX at $20.0 million in Q4 2025, $20.0 million in Q3 2025, and $20.0 million in Q2 2025.